bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study.
- 1 May 1997
- journal article
- abstracts
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 15 (5) , 1916-1922
- https://doi.org/10.1200/jco.1997.15.5.1916
Abstract
PURPOSETo test the hypothesis that high bcl-2 expression and accumulation of p53 protein, both of which should inhibit apoptosis, are associated with a poorer tamoxifen response and a more aggressi...Keywords
This publication has 0 references indexed in Scilit: